Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 83

1.

A Reverse Genetics Approach for the Design of Methyltransferase-Defective Live Attenuated Avian Metapneumovirus Vaccines.

Zhang Y, Sun J, Wei Y, Li J.

Methods Mol Biol. 2016;1404:103-21. doi: 10.1007/978-1-4939-3389-1_7.

PMID:
27076293
2.

Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses.

Whitt MA, Geisbert TW, Mire CE.

Methods Mol Biol. 2016;1403:295-311. doi: 10.1007/978-1-4939-3387-7_16.

PMID:
27076138
3.

Status of vaccine research and development of vaccines for Nipah virus: Prepared for WHO PD-VAC July 30, 2015.

Satterfield BA, Dawes BE, Milligan GN.

Vaccine. 2016 Mar 11. pii: S0264-410X(16)00296-6. doi: 10.1016/j.vaccine.2015.12.075. [Epub ahead of print]

4.

Two highly similar LAEDDTNAQKT and LTDKIGTEI epitopes in G glycoprotein may be useful for effective epitope based vaccine design against pathogenic Henipavirus.

Parvege MM, Rahman M, Nibir YM, Hossain MS.

Comput Biol Chem. 2016 Apr;61:270-80. doi: 10.1016/j.compbiolchem.2016.03.001. Epub 2016 Mar 3.

PMID:
26970211
5.

Regulation of Viral RNA Synthesis by the V Protein of Parainfluenza Virus 5.

Yang Y, Zengel J, Sun M, Sleeman K, Timani KA, Aligo J, Rota P, Wu J, He B.

J Virol. 2015 Dec;89(23):11845-57. doi: 10.1128/JVI.01832-15. Epub 2015 Sep 16.

PMID:
26378167
6.

Henipavirus Encephalitis: Recent Developments and Advances.

Ong KC, Wong KT.

Brain Pathol. 2015 Sep;25(5):605-13. doi: 10.1111/bpa.12278.

PMID:
26276024
7.

A Computational Approach for Designing a Universal Epitope-Based Peptide Vaccine Against Nipah Virus.

Ali MT, Morshed MM, Hassan F.

Interdiscip Sci. 2015 Jun;7(2):177-85. doi: 10.1007/s12539-015-0023-0. Epub 2015 Jul 9.

PMID:
26156209
8.

Neglected tropical diseases among the Association of Southeast Asian Nations (ASEAN): overview and update.

Hotez PJ, Bottazzi ME, Strych U, Chang LY, Lim YA, Goodenow MM, AbuBakar S.

PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003575. doi: 10.1371/journal.pntd.0003575. eCollection 2015 Apr. Review.

9.

Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.

Prescott J, DeBuysscher BL, Feldmann F, Gardner DJ, Haddock E, Martellaro C, Scott D, Feldmann H.

Vaccine. 2015 Jun 4;33(24):2823-9. doi: 10.1016/j.vaccine.2015.03.089. Epub 2015 Apr 10.

PMID:
25865472
10.

Animal models for some important RNA viruses of public health concern in SEARO countries: viral hemorrhagic fever.

Badole SL, Yadav PD, Patil DR, Mourya DT.

J Vector Borne Dis. 2015 Mar;52(1):1-10. Review.

11.

Detailed analysis of the African green monkey model of Nipah virus disease.

Johnston SC, Briese T, Bell TM, Pratt WD, Shamblin JD, Esham HL, Donnelly GC, Johnson JC, Hensley LE, Lipkin WI, Honko AN.

PLoS One. 2015 Feb 23;10(2):e0117817. doi: 10.1371/journal.pone.0117817. eCollection 2015.

12.

A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases.

Oyarzun P, Ellis JJ, Gonzalez-Galarza FF, Jones AR, Middleton D, Boden M, Kobe B.

Vaccine. 2015 Mar 3;33(10):1267-73. doi: 10.1016/j.vaccine.2015.01.040. Epub 2015 Jan 25.

PMID:
25629524
13.

Meeting report VLPNPV: Session 6: Development and characterization.

Rutkowska D.

Hum Vaccin Immunother. 2014;10(10):3074-6. doi: 10.4161/21645515.2014.979645. No abstract available.

PMID:
25458600
14.

A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.

Johnson JB, Borisevich V, Rockx B, Parks GD.

J Virol. 2015 Jan 15;89(2):989-98. doi: 10.1128/JVI.02427-14. Epub 2014 Oct 29.

15.

Mission critical: mobilization of essential animal models for Ebola, Nipah, and Machupo virus infections.

Zumbrun EE.

Vet Pathol. 2015 Jan;52(1):18-20. doi: 10.1177/0300985814556781. Epub 2014 Oct 28.

16.

Rhabdovirus-based vaccine platforms against henipaviruses.

Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ.

J Virol. 2015 Jan;89(1):144-54. doi: 10.1128/JVI.02308-14. Epub 2014 Oct 15.

17.

From risk analysis to risk governance - Adapting to an ever more complex future.

Pfeiffer DU.

Vet Ital. 2014 Jul-Sep;50(3):169-76. doi: 10.12834/VetIt.313.1220.3.

18.

Methyltransferase-defective avian metapneumovirus vaccines provide complete protection against challenge with the homologous Colorado strain and the heterologous Minnesota strain.

Sun J, Wei Y, Rauf A, Zhang Y, Ma Y, Zhang X, Shilo K, Yu Q, Saif YM, Lu X, Yu L, Li J.

J Virol. 2014 Nov;88(21):12348-63. doi: 10.1128/JVI.01095-14. Epub 2014 Aug 13.

19.

Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.

Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC.

Sci Transl Med. 2014 Jun 25;6(242):242ra82. doi: 10.1126/scitranslmed.3008929.

20.

Evaluation of luciferase and GFP-expressing Nipah viruses for rapid quantitative antiviral screening.

Lo MK, Nichol ST, Spiropoulou CF.

Antiviral Res. 2014 Jun;106:53-60. doi: 10.1016/j.antiviral.2014.03.011. Epub 2014 Mar 27.

PMID:
24680955
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk